Sign in
Stories
Assertio Acquires Spectrum Pharmaceuticals
Share
Assertio Holdings Faces Investor Lawsuit
Assertio Holdings Faces Securities Lawsu...
Assertio Lawsuit Allegations Exposed
Overview
API
Assertio Holdings, Inc. has successfully closed its acquisition of Spectrum Pharmaceuticals, Inc., aiming to bolster its market access and growth for all products. The acquisition is anticipated to be announced in the second quarter results call on August 3. Additionally, Jeffrey Vacirca, MD, FACP, has been appointed to Assertio's Board of Directors.
Ask a question
How might the acquisition of Spectrum Pharmaceuticals, Inc. impact Assertio's product portfolio?
What potential challenges might Assertio face in integrating Spectrum Pharmaceuticals, Inc. into its operations?
What strategies could Assertio employ to leverage the market access and growth opportunities presented by the acquisition?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Apr 2023
May 2023
Jun 2023
Jul 2023
Coverage